• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec24
Guo Huaqing Increases Holdings in Caris Life Sciences to 39.02%
11:39
Dec22
Guo Huaqing Increases Holdings in Celltrion Therapeutics
11:26
Dec18
Keji Pharmaceutical-B repurchases shares and extends plan term; Yi Jie Group 增持 shows confidence
13:48
Guo Huaqing Increases Holding of Chi Jun Therapeutics by 30,000 Shares
07:40
Dec16
Keji Pharmaceutical-B repurchased 1,010,000 shares for HKD14.762 million
13:53
Dec11
Keji Pharmaceutical-B Repurchased 1,020,000 Shares
12:16

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 27.89 M, Net Income -41.31 M, EPS -0.0749

Mar18
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 17.6 M, Net Income -237.54 M, EPS -0.4329

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 3.406 M, Net Income -188.88 M, EPS -0.339

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
08635
0.570
+28.09%
+0.125
08573
0.053
+26.19%
+0.011
03830
0.080
+25.00%
+0.016
01570
6.170
+23.40%
+1.170
02315
35.080
+22.23%
+6.380
01875
2.500
+19.05%
+0.400
00145
0.265
+17.78%
+0.040
02330
0.226
+17.71%
+0.034
00209
0.173
+16.89%
+0.025
View More